- The Administration of President Joe Biden announced changes to the travel restrictions sparked by the pandemic.
- The US reported when it will begin to apply new rules and what will be required of travelers.
- Travel restrictions to the US have been in place for months due to the crisis unleashed by the coronavirus.
The United States will ease some travel restrictions starting in November, when it will ask all foreigners who visit the country to be fully vaccinated against Covid-19, it was announced this Monday, September 20.
All foreigners traveling to the United States must show proof of vaccination before boarding and a negative test performed within three days prior to the flight, reported the White House Covid-19 coordinator, Jeff Zients, who announced the new politics, the AP news agency reported.
The US will ease travel restrictions
On the other hand, the government of President Joe Biden will also tighten the rules for Americans who have not been vaccinated, since they will have to be examined one day before leaving the United States, and the same when they return. Additionally, fully vaccinated passengers will not be required to quarantine.
The new policy replaces those first announced by the Donald Trump government last year and later toughened by Biden, according to which the entry into the country of non-citizens who had been in the United Kingdom in the previous 14 days, the European Union, China, India, Iran, the Republic of Ireland, Brazil and South Africa.
New rules on travel restrictions to the US
“This policy is up to the individual and not the country, so it is a more robust strategy,” Zients said. In addition, the Centers for Disease Control and Prevention (CDC for its acronym in English) will ask airlines to collect data from the contacts of international passengers, in order to facilitate the follow-up of nearby people if necessary, he added.
It was not immediately clear which vaccines will be accepted by the United States, or whether the government will accept those that have not been approved in the country. White House Covid-19 coordinator Jeff Zients stated that that decision will be in the hands of the CDC.
New policy on travel restrictions kicks off in November
The new policy will take effect in early November, giving airlines and other travel companies time to implement the new requirements, Zients said, according to the AP news agency report.
ABC News, NBC News, among other means, have also reported the announcement of the Biden Administration to ease travel restrictions, by air, starting in November, when the separation of some families from March 2020 due to the pandemic would end.
Benefit for travelers on the list of countries restricted by Covid-19
According to ABC News, the announcement comes just as President Joe Biden prepares to address the United Nations General Assembly in New York on Monday and a day before meeting UK Prime Minister Boris at the White House. Johnson.
The new rules will ease travel restrictions that limited entry to the United States in many cases for non-citizens who had recently been to 33 countries, including many European nations and the United Kingdom, regardless of vaccination status. But for travelers outside of those countries, the new system will establish stricter requirements that could be a barrier for those living in countries where vaccines are scarce, NBC News reported.
Pfizer Says Its COVID-19 Vaccine Works In Children Ages 5 To 11
Pfizer’s vaccine against COVID-19 works in children between 5 and 11 years old, the company announced on Monday, which will soon request authorization in the United States for that age group, a key step to start vaccinations in young children. reviewed The Associated Press.
The vaccine made by Pfizer and its German partner BioNTech is now available in the United States for people 12 years of age and older. But now that children are back in school and the contagious delta variant of the virus has caused a large increase in pediatric infections, many families are anxiously awaiting the opportunity to vaccinate their youngest children.
Pfizer vaccine works in children between 5 and 11 years old
The pharmacist tried a dose much lower for children of that age group, a third of the doses administered so far. After the second dose, however, children between the ages of 5 and 11 showed levels of antibodies to fight coronavirus as strong as those of adolescents and young adults, Dr. Bill Gruber, senior vice president of Pfizer, told The Associated Press.
The reduced dose was also shown to be safe, with temporary side effects – such as arm discomfort, fever or pain – similar to or less than those of adolescents, he noted. “I think we really hit the mark,” said Gruber, who is also a pediatrician.
Pfizer plans to apply for FDA approval this month
The firms plan to apply this month to the US Food and Drug Administration (FDA) for emergency use of the vaccine in that age group. Applications would then be sent to the European and British regulatory authorities.
FDA chief Dr. Peter Marks told the AP this month that once Pfizer released the results of its trials, his agency would study the data “we hope in a matter of weeks” to determine whether the drugs were safe and effective for Small children.
Other countries started vaccination
Many Western countries have limited vaccinations for now starting at age 12 until they have data on the correct dose and its safety in younger patients. However, last week Cuba began to immunize children from two years of age with its local vaccine, and the Chinese authorities have authorized the use of two of its brands from 3 years.
Although children are less at risk of becoming seriously ill or dying from COVID-19 than older patients, more than 5 million children have tested positive since the start of the pandemic in the United States and at least 460 have died, according to the American Academy of Sciences. Pediatrics. Cases in children have risen dramatically as the delta variant spread across the country.
Cases in children have increased due to delta variant
“I feel a great sense of urgency” to offer the vaccine for children under 12, Gruber said. “There is a pent-up demand from parents to be able to return their children to a normal life,” he added, according to the aforementioned media report.
Pfizer said it studied the lowest dose in 2,268 preschool and elementary school students. The FDA required an immune study to show that young children developed immune responses that have already been shown to be protective in adolescents and adults. That was what Pfizer presented on Monday, and not a scientific journal.
All side effects are unknown
The study is still ongoing, and there have not yet been enough cases of COVID-19 to compare the numbers between those vaccinated and those who received a placebo, something that could offer more information. The study is not large enough to detect extremely rare side effects, such as heart inflammation sometimes identified after the second dose, especially in young men.
Marks, the FDA chief, said pediatric studies had to be large enough to rule out higher risks for young children. Gruber said that once the drug is licensed for use in young children, those vaccinated will be meticulously monitored like other patients to identify rare risks.